Zurich Cantonal Bank’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
Other funds holding RLAY
SIAU
CC
PA
CC
NI
Zurich Cantonal Bank's RLAY Position: Q2 2026 in Review
Zurich Cantonal Bank increased its Relay Therapeutics (RLAY) stake by 2.4% in Q2 2026, buying an estimated $23.2K and bringing the position to 68,334 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #1397.
Zurich Cantonal Bank first reported a position in RLAY in Q3 2021 and has held it in 20 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.
- Zurich Cantonal Bank held 68,334 shares of Relay Therapeutics worth $1.28M as of Q2 2026.
- Zurich Cantonal Bank bought 1,595 Relay Therapeutics shares in Q2 2026, an estimated $23.2K.
- Relay Therapeutics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1397 holding.
- Zurich Cantonal Bank first reported a position in Relay Therapeutics in Q3 2021 and has held it in 20 quarters since.
- 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.
Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.